URINARY MICROALBUMIN AND SERUM ADIPONECTIN AS EARLY MARKERS OF SUBCLINICAL KIDNEY DYSFUNCTION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD/MASLD): A PROSPECTIVE CROSS-SECTIONAL STUDY

Аннотация

NAFLD, MASLD, chronic kidney disease, urinary microalbumin, adiponectin, early diagnosis, subclinical kidney dysfunction, ROC analysis, AUROC, CKD-EPI 2021, biomarkers, internal medicine, nephroprotection, Central Asia.